128 related articles for article (PubMed ID: 29955477)
1. Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital.
Gunterus A; Lopchuk S; Dunn C; Floyd R; Normandin B
Ment Health Clin; 2016 Sep; 6(5):242-247. PubMed ID: 29955477
[TBL] [Abstract][Full Text] [Related]
2. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
Saokaew S; Maphanta S; Thangsomboon P
Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
[TBL] [Abstract][Full Text] [Related]
3. Descriptive Analysis of Acceptance by Prescribers and Economic Benefit of Pharmacist Recommended Interventions in a Critical Care Unit.
Lee Y; Gettman L
Innov Pharm; 2018; 9(2):1-20. PubMed ID: 34007688
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
Chen PZ; Wu CC; Huang CF
J Oncol Pharm Pract; 2020 Jun; 26(4):866-872. PubMed ID: 31566112
[TBL] [Abstract][Full Text] [Related]
6. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital.
Amir M; Zehra A; Munawar R; Gul W; Fatima T; Khan Y; Jaffery R; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):533-539. PubMed ID: 38362677
[TBL] [Abstract][Full Text] [Related]
8. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
9. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.
Lada P; Delgado G
Am J Health Syst Pharm; 2007 Jan; 64(1):63-8. PubMed ID: 17189582
[TBL] [Abstract][Full Text] [Related]
10. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
Chen CC; Hsiao FY; Shen LJ; Wu CC
Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
[TBL] [Abstract][Full Text] [Related]
11. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
Kopp BJ; Mrsan M; Erstad BL; Duby JJ
Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
[TBL] [Abstract][Full Text] [Related]
12. Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.
Houso A; Hamdan M; Falana H
Saudi Pharm J; 2022 Dec; 30(12):1718-1724. PubMed ID: 36601501
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
[TBL] [Abstract][Full Text] [Related]
14. PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.
Rech MA; Gurnani PK; Peppard WJ; Smetana KS; Van Berkel MA; Hammond DA; Flannery AH
Crit Care Explor; 2021 Dec; 3(12):e0594. PubMed ID: 34913039
[TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
[TBL] [Abstract][Full Text] [Related]
16. The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.
Abdulrhim S; Sankaralingam S; Ibrahim MIM; Awaisu A
Prim Care Diabetes; 2020 Oct; 14(5):393-400. PubMed ID: 31926868
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
18. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
Sjölander M; Lindholm L; Pfister B; Jonsson J; Schneede J; Lövheim H; Gustafsson M
Res Social Adm Pharm; 2019 Mar; 15(3):287-291. PubMed ID: 29778344
[TBL] [Abstract][Full Text] [Related]
19. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
20. PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study.
Rech MA; Adams W; Smetana KS; Gurnani PK; Van Berkel Patel MA; Peppard WJ; Hammond DA; Flannery AH
Crit Care Explor; 2021 Apr; 3(4):e0406. PubMed ID: 33912836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]